Rethinking atherogenic risk: is apolipoprotein B a better biomarker?

Clin Chem Lab Med. 2026 May 11. doi: 10.1515/cclm-2026-0624. Online ahead of print.

Author

Giuseppe Lippi¹

Affiliation

¹ Section of Clinical Biochemistry, University of Verona, Verona, Italy.

PMID: 42106163
DOI: 10.1515/cclm-2026-0624

No abstract available

Keywords: LDL-cholesterol; apolipoprotein B; cardiovascular disease; non HDL-cholesterol.

Publication types

Letter